DESVENLAFAXINE

Substance profile for UNII NG99554ANW, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DESVENLAFAXINE
Structure render from PubChem CID 125017

Substance Identity#

UNII
NG99554ANW
Preferred term
DESVENLAFAXINE
Registry number
93413-62-8
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C16H25NO2
Chemical structure for DESVENLAFAXINE
Structure render from PubChem CID 125017

Chemical And Database Identifiers#

SMILES
CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2
RxCUI
734064
PubChem
125017
NCIt
C61703
INN ID
8361

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DESVENLAFAXINEACTIVE MOIETYNG99554ANWThese highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 20081
DESVENLAFAXINEACTIVE MOIETYNG99554ANWPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3747
DESVENLAFAXINEACTIVE MOIETYNG99554ANWPRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2068
DESVENLAFAXINEACTIVE MOIETYNG99554ANWPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
DESVENLAFAXINEACTIVE INGREDIENTNG99554ANWKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
DESVENLAFAXINEACTIVE MOIETYNG99554ANWKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
DESVENLAFAXINEACTIVE INGREDIENTNG99554ANWDESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10
DESVENLAFAXINEACTIVE MOIETYNG99554ANWDESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10
DESVENLAFAXINEACTIVE MOIETYNG99554ANWDESVENLAFAXINE TABLET, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]10
DESVENLAFAXINEACTIVE INGREDIENTNG99554ANWKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
DESVENLAFAXINEACTIVE MOIETYNG99554ANWKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
DESVENLAFAXINEACTIVE MOIETYNG99554ANWPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]10
DESVENLAFAXINEACTIVE MOIETYNG99554ANWDESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC]7
DESVENLAFAXINEACTIVE INGREDIENTNG99554ANWDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
DESVENLAFAXINEACTIVE MOIETYNG99554ANWDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
DESVENLAFAXINEACTIVE MOIETYNG99554ANWPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]1